CanaFarma Hemp Products Corp. (CSE:CNFA)

Get Top Rated Stock Alerts Active Traders Depend On

Sign Up Today For FREE News Driven Alerts

CANAFARMA HEMP PRODUCTS CORP. OUTLINES IMMEDIATE PLANS FOR INNOVATIVE HEMP OIL-INFUSED ANTI-AGING SKIN CARE LINE

Vancouver, BC – August 18, 2020  – CanaFarma Hemp Products Corp. (CSE: CNFA) (the “Company” or “CanaFarma”) is pleased to announce the launch of its comprehensive and innovative hemp oil-infused Anti-Aging skin care line to market.

 

Formulated for every-day use on the face and neck, our Anti-Aging Line consists of a Day Cream Repair, Night Cream Repair, Eye Serum, Men’s Cream, along with a high-end Toner and Cleanser.

 

Clinical studies of people ages 25 to 65 demonstrated the Day Cream visibly affected the length and depth of wrinkles, brightens skin noticeably and takes years off the skin’s appearance.  CanaFarma’s special formulation of sesame protein, together with phytocompounds, is targeted to reduce inflammation and restore collagen and elastins in the dermis.  The combination of proteins and natural restorative ingredients like honey extract and grape seed oil are designed to prevent future damage by creating a defensive bed on the dermis layer.  Our formulation includes a patent-pending, ingredient base of proteins from oak bark extract, which when formulated properly, is expected to tighten the skin, moisturize the epidermal and dermal layers and plump sagging skin, making the face glow and look younger.  CanaFarma’s peptides allow for the restoration of collagen and add plump elastins to the skin, restoring its youthful appearance.   The addition of full-spectrum hemp is included to help reduce inflammation in the skin, which is expected to restore skin and shield it from external consequences of damage.

 

David Lonsdale, the CEO of CanaFarma, commented, “We are very excited to be entering the Anti-Aging market with our hemp oil-infused skin care product line. The Anti-Aging market has been estimated to be over $50 billion and growing at over 5% annually(1).”

 

Notes: (1) See https://www.statista.com/statistics/509679/value-of-the-global-anti-aging-market/#:~:text=In%202018%2C%20the%20global%20anti,percent%20between%202018%20and%202023.

 

About CanaFarma Hemp Products Corp.

 

CanaFarma Hemp Products Corp. is a full-service company operating in the hemp industry offering a full range of hemp-related products and services to the consumer wellness market. These products and services include growing top-quality hemp, providing hemp-processing services, and offering hemp-based products to consumers utilizing a well-established direct-to-consumer marketing approach.

 

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to general business, economic, competitive, political and social uncertainties; and delay or failure to receive board, shareholder or regulatory approvals.  Readers should not place undue reliance on forward-looking statements.  The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

  

FOR FURTHER INFORMATION, PLEASE CONTACT:

 

David Lonsdale

Chief Executive Officer

Phone: (214) 704-7942

Email: david@canafarmacorp.com

 

Source:  CanaFarma Hemp Products Corp.

CANAFARMA HEMP PRODUCTS CORP. ANNOUNCES DEVELOPMENT PLANS FOR A BIOEQUIVALENT DRUG TO HYDROXYCHLOROQUINE

Vancouver, BC – June 9 2020 – CanaFarma Hemp Products Corp. (CSE:CNFA) (the “Corporation” or “CanaFarma”) is pleased to announce that it has agreed to engage PharmOps, an FDA approved pharmaceutical company, to develop a bioequivalent material to Hydroxychloroquine. Pharm Ops is a private company that manufactures pharmaceutical and nutraceutical products at its cGMP (current Good Manufacturing Practices) licensed facility in New Jersey.

 

On April 24th 2020, CanaFarma signed an LOI to acquire PharmOps Ltd., and its pharmaceutical and nutraceutical manufacturing facility. Today, as due diligence continues on the acquisition, the two companies have agreed to work together to develop a bioequivalent material to Hydroxychloroquine. CanaFarma shall use its expertise in Cannabinoids, along with an identified API source, for water soluble materials to create this bioequivalent material, and fast track through the Abbreviated New Drug Application (“ANDA”), a 6 month stability test as required by the FDA. The parties have also contracted with the aforementioned supplier of API material to produce a batch of the bioequivalent material and initiate safety studies right away.

 

During public health emergencies, medical countermeasures (“MCMs”) may be needed to prevent or treat diseases or conditions caused by chemical, biological, radiological, or nuclear (“CBRN”) or emerging infectious disease threats, like pandemic influenza. MCMs are medical products such as drugs, vaccines, diagnostic tests, and other medical equipment and supplies, needed to respond to emergencies involving such threats. The Emergency Use Authorization (“EUA”) authority allows the FDA to help strengthen the Nation’s public health protections against CBRN threats by facilitating the availability and use of MCMs needed during public health emergencies.

 

Under section 564 of the Federal Food, Drug, and Cosmetic Act (FD&C Act), the FDA Commissioner may allow unapproved medical products or unapproved uses of approved medical products to be used in an emergency to diagnose, treat, or prevent serious or life-threatening diseases or conditions caused by CBRN threat agents when there are no adequate, approved, and available alternatives.

 

An ANDA contains data which is submitted to the FDA for the review and potential approval of a generic drug product. Once approved, an applicant may manufacture and market the generic drug product to provide a safe, effective, lower cost alternative to the brand-name drug it references.

 

The FDA, via the EUA, has allowed for a more stream-lined approval process of certain drugs due to Covid-19 Pandemic. One such drug that has been widely publicized is Hydroxychloroquine, approved in the 1940’s for Malaria under the Trade name of Plaquenil™. Although this product is already available on the market as a generic version as 200 mg Tablets manufactured by Mylan, Sandoz, Teva and Watson, its recent publicity of being used prophylactically in combination with Azithromycin to ward off the Covid-19 virus has created an acute shortage for all patients, including those that are using this product as an immuno-suppressant . Furthermore, although there is some controversy as to its effectiveness in the fight against Covid-19, there have been reports of healthcare professionals either taking it or hoarding it.1 President Trump has been a strong advocate of the product and recently sent 2 billion doses of Hydroxychloroquine to Brazil to assist in its fight against the deadly virus.2 The Company is not making any express or implied claims that it will be successful in developing its proposed product, nor that its proposed product will have the ability to eliminate, cure or contain the Covid-19 (or SARS-2 Coronavirus) at this time.

 

References:

  1. See https://www.wbur.org/commonhealth/2020/03/22/hydroxychloroquine-treatment-drug-coronavirus-hoarding.
  2. See https://www.reuters.com/article/us-health-coronavirus-usa-brazil/u-s-sends-brazil-2-million-doses-of-hydroxychloroquine-drug-touted-by-trump-idUSKBN2370RU.

 

 

About CanaFarma Hemp Products Corp.

CanaFarma Hemp Products Corp. is a full-service company operating in the hemp industry offering a full range of hemp-related products and services to the consumer wellness market. These products and services include growing top-quality hemp, providing hemp-processing services, and offering hemp-based products to consumers utilizing a well-established direct-to-consumer marketing approach.

 

 

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to general business, economic, competitive, political and social uncertainties; and delay or failure to receive board, shareholder or regulatory approvals. Readers should not place undue reliance on forward-looking statements. The Corporation disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

 

FOR FURTHER INFORMATION, PLEASE CONTACT:

David Lonsdale

Chief Executive Officer

Phone: (214) 704-7942

Email: david@canafarmacorp.com

 

Source:  CanaFarma Hemp Products Corp.

CanaFarma Hemp Products Corp. Appoints Tyrone Ross Jr. As Vice President Communications

Vancouver, BC – June 2, 2020 – CanaFarma Hemp Products Corp. (CSE:CNFA) (the “Company” or “CanaFarma”) is pleased to announce the appointment of Tyrone Ross Jr. as its Vice President Communications.

 

In his position as Vice President Communications, Mr Ross will play a key role in helping to deliver CanaFarma’s message to both investors and customers. CanaFarma is a full-service company operating in the hemp industry offering a full range of hemp-related products and services to the consumer wellness market. As such there is a great deal of information to be shared with the investor and customer communities and Mr. Ross will play an important part in delivering the Company’s message.

 

Tyrone Ross is the founder and CEO of 401stc (www.401.run), an early-stage company advisor, entrepreneur and financial consultant. Investment News recognized him as one of the “40 under 40” (1), and Wealth Management.com described him as one of the top 10 advisors set to change the industry in 2019(2). Planning.com named him one of the “20 people who will change wealth management in 2020”(3).

 

David Lonsdale, CEO of CanaFarma said, “We are very pleased to welcome Tyrone to the CanaFarma team. He is an exceptionally talented individual who will help significantly in communicating the Company’s message”.

 

About CanaFarma Hemp Products Corp.

CanaFarma Hemp Products Corp. is a full-service company operating in the hemp industry offering a full range of hemp-related products and services to the consumer wellness market. These products and services include growing top-quality hemp, hemp-processing services, and offering hemp-based products to consumers utilizing a well-established direct-to-consumer marketing approach.

 

References:

  1. https://www.investmentnews.com/40-under-40-awards-archive-2019
  2. https://www.wealthmanagement.com/people/ten-watch-2019-0
  3. https://www.financial-planning.com/list/20-people-who-will-change-wealth-management-in-2020

 

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to general business, economic, competitive, political and social uncertainties; and delay or failure to receive board, shareholder or regulatory approvals. Readers should not place undue reliance on forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

 

FOR FURTHER INFORMATION, PLEASE CONTACT:

David Lonsdale
Chief Executive Officer
Phone: (214) 704-7942
Email: david@canafarmacorp.com

 

SOURCE: CanaFarma Hemp Products Corp.

Canafarma Hemp Products Corp. Outlines Its Immediate Plans for Continuous Development of Innovative Hemp Oil-Based Consumer Products

Vancouver, BC – May 25, 2020 – CanaFarma Hemp Products Corp. (CSE:CNFA) (the “Company” or “CanaFarma”) is pleased to outline its continued development strategy for bringing new and innovative hemp oil-based products to market, by expanding its Confectionary, Beauty and Pain Relief verticals.

 

While the Company has previously announced individual products, the purpose of this press release is to provide an understanding of its overall vertical expansion strategy across key business segments. CanaFarma’s hemp oil-based consumer products will be focused around three key areas: Confectionary, which will deliver chewing gum and confectionary-based products; Beauty, which will incorporate acne solutions, face creams and serums; and Pain Relief, which will include topical creams and oils.

 

Today, the Company sells seven SKUs – YOOFORIC™ Chewing Gum in the Confectionary segment, Hemp-Oil drops in four flavors, and its YOOFORIC™ Joint & Muscle Cream in the Pain Relief sector.

 

David Lonsdale, CEO of CanaFarma said, “We are very pleased with our product expansion strategy, and we expect that this additional clarity will help the marketplace to easily understand where each new product falls in our overall strategy as we continue to develop and announce further product offerings.”

 

About CanaFarma Hemp Products Corp.

 

CanaFarma Hemp Products Corp. is a full-service company operating in the hemp industry offering a full range of hemp-related products and services to the consumer wellness market. These products and services include growing top-quality hemp, providing hemp-processing services, and offering hemp-based products to consumers utilizing a well-established direct-to-consumer marketing approach.

 

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to general business, economic, competitive, political and social uncertainties; and delay or failure to receive board, shareholder or regulatory approvals. Readers should not place undue reliance on forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

 

FOR FURTHER INFORMATION, PLEASE CONTACT:

David Lonsdale
Chief Executive Officer
Phone: (214) 704-7942
Email: david@canafarmacorp.com

 

SOURCE: CanaFarma Hemp Products Corp.

About CanaFarma Hemp Products


BUILD BRANDS. DELIVER DIRECT.

 

CanaFarma is building a fully integrated, multi-faceted Hemp products brand company. From plant to finished good, CanaFarma creates high grade hemp-based formulations supported by science and innovation. Designed to meet consumer demand in this rapidly growing market, CanaFarma’s proprietary brand machine and its direct-to-consumer demand marketing engine poise this company to be an industry leader in the branded hemp product space.

 

THE BRAND MACHINE

 

Developed by Science, Powered by the Demand Marketing Engine, Fueled by Expertise

 

We develop products backed by science and innovation. Then they are fed into our Demand Marketing Machine.

 

>> Products backed by science that deliver higher efficacy rates

>> Build brands that speak to consumers

>> Low cost, low risk, scalable marketing program to drive revenue

>> CanaFarma’s executives have over 30 years experience in direct-to-consumer marketing in the health and wellness

 

DEMAND MARKETING ENGINE

 

Our proprietary and proven Demand Marketing Engine powers the Brand Machine.

 

>> Delivers In-Demand Products Direct to Consumers

>> Bypasses Traditional Retail Hurdles

>> Performance Based System = Low Marketing Cost

>> Achieves Rapid Scale

>> Proven: $4M in Revenue in First 6 Months

 

OUR BRANDS

 

YOOFORIC
Hemp Oil Infused Chewing Gum

yooforic gum>> Organically Grown Full Spectrum Hemp Oil
>> No High
>> Patented Time-Released Delivery Method
>> Best Clinically Verified Absorption Rate: 84%
>> Manufactured in a GMP Certified and FDA Registered Facility
>> Gluten-Free, Sugar Free, Non-GMO
>> Vegan
>> Rich in Omega 3 and Omega 6 Fatty Acids
>> Supports Dental Health: Contains Xylitol
>> Tastes Great — Long-Lasting Flavor
>> Discrete and Convenient – Can Be Used Anywhere
>> The superior patented time-release delivery method allows for maximum absorption without waste resulting in the Best Clinically Verified Absorption Rate on the Market – 84%! YOOFORIC is formulated with only the highest quality Full Spectrum Hemp Oil that is rich in naturally occurring phytocannabinoids, including CBD, vitamins, nutrients, Omega 3, Omega 6, and complete protein. Mastication, the scientific term for chewing, has been clinically shown to have its own health benefits which makes this functional chewing gum the best hemp oil delivery method on the market.

 

YOOFORIC
Hemp Oil Tinctures

 

yooforic oil passion>> Organically Grown Full Spectrum Hemp  – Oil containing an entourage of naturally  -occurring phytocannabinoids – including CBD!
>> No High
>> Manufactured in a GMP Certified and FDA Registered Facility
>> Gluten-Free, Sugar Free, Non-GMO
>> Vegan
>> Rich in Omega 3 and Omega 6 Fatty Acids
>> YOOFORIC contains powerful Full Spectrum Hemp Oil: Full spectrum hemp oil contains all of the naturally occurring phytocannabinoids found in the hemp plant, including CBD!

These phytocannabinoids work together synergistically to produce greater health benefits better than any one isolated phytocannabinoid, such as the case with CBD isolate.

 

Organically Grown Hemp Oil and Vegan: YOOFORIC Full Spectrum Hemp oil is cultivated and packaged in the USA following the strictest guidelines to ensure our products are free from preservatives, fillers, or GMOs. Available in 4 delicious flavors.

 

YOOFORIC
Hemp Oil Infused Cream

 

yooforic cream>> Hemp Oil Rich in Phytocannabinoids
>> Premium Ingredients specifically designed to Target Inflammation, Chronic Joint and Muscle Soreness
>> Relaxing Aromatic Botanical Fresh Mint Scent
>> Manufactured in FDA. Registered, Audited and GMO Certified Facility
>> YOOFORIC Hemp Oil Infused Cream is a botanical blend of powerful phytocannabinoids including CBD plus cooling menthol. The light texture is absorbed thoroughly, and does not leave a greasy residue. When applied directly to the aching area, this botanical blend engages cannabinoid receptors in the skin, providing relief that will leave your muscles and joints feeling “YOOFORIC.”

 

HERBAL STATE OF MIND
Hemp Oil Tincture

 

hemp-oil>> Organically Grown Full Spectrum Hemp Oil
>> No High
>> Manufactured in a GMP Certified and FDA Registered Facility
>> Gluten-Free, Sugar Free
>> Non-GMO
>> Certified Vegan
>> Rich in Omega 3 and Omega 6 Fatty Acids
>> Herbal State of Mind Full Spectrum Hemp Oil contains all of the naturally occurring phytocannabinoids including CBD found in the hemp plant. Full spectrum hemp oil is superior to isolates. The various phytocannabinoids work together creating even more benefit than any one can on its own.

 

HERBAL STATE OF MIND
Hemp Oil Cream

herbal state cream>> Premium Ingredients designed to target
>> Inflammation, Chronic Joint and Muscle Soreness
>> Relaxing Scent
>> Absorbs Quickly
>> Manufactured in a GMP Certified and FDA Registered Facility
>> Herbal State of Mind Hemp Oil Infused Cream is a lightly scented, soothing cream that can be used day or night. Rich in phytocannabinoids from hemp, including naturally occurring CBD, it helps provide targeted relief for sore and achy muscles with your first application.

 

Source:  https://www.canafarmacorp.com/

Disclaimer

FN Media Group LLC (FNMG) owns and operates FinancialNewsMedia.com (FNM) which is a third party publisher that disseminates electronic information through multiple online media channels. FNMG’s intended purposes are to deliver market updates and news alerts issued from private and publicly trading companies as well as providing coverage and increased awareness for companies that issue press to the public via online newswires. FNMG and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. The companies that are discussed in this release may or may not have approved the statements made in this release. Information in this release is derived from a variety of sources that may or may not include the referenced company’s publicly disseminated information. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. While this information is believed to be reliable, such reliability cannot be guaranteed. FNMG disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. This release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies discussed in this release is highly speculative and carries a high degree of risk. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. This release is not without bias, and is considered a conflict of interest if compensation has been received by FNMG for its dissemination. To comply with Section 17(b) of the Securities Act of 1933, FNMG shall always disclose any compensation it has received, or expects to receive in the future, for the dissemination of the information found herein on behalf of one or more of the companies mentioned in this release. For current services performed FNMG has been compensated forty six hundred dollars for CanaFarma Hemp Products Corp. current news coverage by a non-affiliated third party.  FNMG HOLDS NO SHARES OF CanaFarma Hemp Products Corp.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.

Sign Up & Get FREE News Alerts From FNM Today!